{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:06:27Z","timestamp":1780959987875,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.vaccine.2025.128121","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T13:10:59Z","timestamp":1766063459000},"page":"128121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Advancements in monitoring adverse events following immunization in Iraq: Insights from the CIVIE project 2022\u20132023"],"prefix":"10.1016","volume":"72","author":[{"given":"Firas","family":"Jabbar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal A.","family":"Kadhim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riyadh A.","family":"Alhilfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israa S.","family":"Al Khafaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzan","family":"Salam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monako","family":"Kuroiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Tabche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Rawaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wisam Hussein","family":"Altememi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.128121_bb0005","series-title":"Vaccines and Immunization WHO website","author":"WHO","year":"2023"},{"key":"10.1016\/j.vaccine.2025.128121_bb0010","author":"WHO"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128121_bb0015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00103-019-03062-1","article-title":"National immunization programmes","volume":"63","author":"Cherian","year":"2020","journal-title":"Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"},{"issue":"2","key":"10.1016\/j.vaccine.2025.128121_bb0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12098-017-2532-9","article-title":"Vaccine safety and surveillance for adverse events following immunization (AEFI) in India","volume":"85","author":"Joshi","year":"2018","journal-title":"The Indian Journal of Pediatrics"},{"key":"10.1016\/j.vaccine.2025.128121_bb0025","doi-asserted-by":"crossref","first-page":"2911333","DOI":"10.1155\/2022\/2911333","article-title":"Adverse events following immunization with COVID-19 vaccines: a narrative review","volume":"2022","author":"Bhandari","year":"2022","journal-title":"Biomed Res Int"},{"issue":"46","key":"10.1016\/j.vaccine.2025.128121_bb0030","doi-asserted-by":"crossref","first-page":"7183","DOI":"10.1016\/j.vaccine.2020.09.017","article-title":"Improving the quality and use of immunization and surveillance data: summary report of the working Group of the Strategic Advisory Group of experts on immunization","volume":"38","author":"Scobie","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128121_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-019-6709-1","article-title":"Defining & assessing the quality, usability, and utilization of immunization data","volume":"19","author":"Bloland","year":"2019","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128121_bb0040","first-page":"21","article-title":"A realist review of what works to improve data use for immunization","volume":"10","author":"PATH","year":"2005","journal-title":"Policy"},{"key":"10.1016\/j.vaccine.2025.128121_bb0045","doi-asserted-by":"crossref","DOI":"10.26633\/RPSP.2019.28","article-title":"Assessing electronic immunization registries: the Pan American health organization experience","volume":"43","author":"Danovaro-Holliday","year":"2019","journal-title":"Rev Panam Salud Publica"},{"issue":"2","key":"10.1016\/j.vaccine.2025.128121_bb0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/bmjqs-2020-011717","article-title":"How does the effectiveness of strategies to improve healthcare provider practices in low-income and middle-income countries change after implementation? Secondary analysis of a systematic review","volume":"31","author":"Arsenault","year":"2022","journal-title":"BMJ Quality & Safety"},{"key":"10.1016\/j.vaccine.2025.128121_bb0055","series-title":"Annual report of the EPI department 2022. In: EPI, editor.: Iraqi MOH","author":"Iraqi Ministry of Health","year":"2023"},{"key":"10.1016\/j.vaccine.2025.128121_bb0060","series-title":"Iraq - COVID-19 Vaccination Project (English)","author":"World Bank","year":"2021"},{"key":"10.1016\/j.vaccine.2025.128121_bb0065","series-title":"21st ISoP Annual Meeting \u201cA New Era of Pharmacovigilance: Challenges and Opportunities\u201d 20\u201323 September 2022 Verona, Italy. Drug Saf 45, 1111\u20131327","year":"2022"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2025.128121_bb0070","first-page":"S208","article-title":"CDC\u2019S COVID-19 international vaccine implementation and evaluation program and lessons from earlier vaccine introductions","volume":"28","author":"Soeters","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128121_bb0075","first-page":"3","article-title":"Digital health records: an essential yet neglected step in Iraq. Oxford open digital","author":"Mosa","year":"2025","journal-title":"Health"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128121_bb0080","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3390\/vaccines9050456","article-title":"Post-marketing active surveillance of adverse reactions following influenza cell-based Quadrivalent vaccine: an Italian prospective observational study","volume":"9","author":"Stefanizzi","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.128121_bb0085","series-title":"Workshops on Vaccine Safety Basics and AEFI Surveillance in Primary Healthcare Districts in Iraq","author":"EMPHNET","year":"2022"},{"key":"10.1016\/j.vaccine.2025.128121_bb0090","series-title":"3-day training for the causality assessment committee 2-day meeting Analysis and Improvement PlanCIVIE and Outbreak Response II\/ Iraq","author":"EMPHNET","year":"2023"},{"key":"10.1016\/j.vaccine.2025.128121_bb0095","article-title":"Interrater reliability of causality assessment for serious adverse events following immunization. - Extract from report of GACVS meeting of 6-7 December 2017, published in the WHO Weekly Epidemiological Record of 19 January 2018.\u00a0 WHO website","author":"World Health Organization.","year":"2018","journal-title":"WHO"},{"key":"10.1016\/j.vaccine.2025.128121_bb0100","author":"Harmonia"},{"key":"10.1016\/j.vaccine.2025.128121_bb0105","author":"Association of Healthcare Journalists"},{"key":"10.1016\/j.vaccine.2025.128121_bb0110","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s002280050314","article-title":"Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union","volume":"52","author":"Belton K, Group EPR","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.128121_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2017.e00331","article-title":"Knowledge, practice and approaches of health professionals to adverse events following immunization and their reporting in Albania","volume":"3","author":"Mehmeti","year":"2017","journal-title":"Heliyon"},{"issue":"12","key":"10.1016\/j.vaccine.2025.128121_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277197","article-title":"Optimising reporting of adverse events following immunisation by healthcare workers in Ghana: a qualitative study in four regions","volume":"17","author":"Aborigo","year":"2022","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128121_bb0125","doi-asserted-by":"crossref","first-page":"2083865","DOI":"10.1080\/21645515.2022.2083865","article-title":"Barriers to healthcare workers reporting adverse events following immunization in Zhejiang province, China","volume":"18","author":"Lv","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.128121_bb0130","series-title":"Summary of adverse events following immunization reported in Switzerland during 2022","author":"Swissmedic DSoM","year":"2022"},{"key":"10.1016\/j.vaccine.2025.128121_bb0135","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00228-010-0944-9","article-title":"Adverse events following immunization in children: retrospective analysis of spontaneous reports over a decade","volume":"67","author":"Aagaard","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.vaccine.2025.128121_bb0140","series-title":"Descriptive study of the adverse events following immunization (AEFIs) surveillance system in Zimbabwe","author":"Nyambayo","year":"2022"},{"key":"10.1016\/j.vaccine.2025.128121_bb0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.clicom.2022.05.003","article-title":"COVID-19 vaccine safety and adverse event analysis from Pakistan","volume":"2","author":"Hasan","year":"2022","journal-title":"Clinical Immunology Communications"},{"issue":"10","key":"10.1016\/j.vaccine.2025.128121_bb0150","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s40261-022-01191-1","article-title":"Active safety surveillance of four types of COVID-19 vaccines: a national study from Jordan","volume":"42","author":"Abdel-Qader","year":"2022","journal-title":"Clin Drug Investig"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128121_bb0155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13690-024-01260-1","article-title":"Effectiveness of educational interventions for healthcare workers on vaccination dialogue with older adults: a systematic review","volume":"82","author":"Wennekes","year":"2024","journal-title":"Arch Public Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:54:15Z","timestamp":1768452855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25014197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":31,"alternative-id":["S0264410X25014197"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128121","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancements in monitoring adverse events following immunization in Iraq: Insights from the CIVIE project 2022\u20132023","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128121"}}